To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    European Quality Management in Healthcare Market size was valued at USD 1078.24 Million in 2024 and is poised to grow from USD 1183.91 Million in 2025 to USD 2501.13 Million by 2033, growing at a CAGR of 9.8% during the forecast period (2026–2033). 

    European quality management in the healthcare market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Eurosets (Italy) ', 'Vivasure Medical (Ireland) ', 'ALBOMED (Germany) ', 'Antigon (France) ', 'Cardiolex Medical (Germany) ', 'Dornier MedTech (Germany) ', 'Duearity (Italy) ', 'Arkema (France) ', 'BioTop Medical (Germany) ', 'Icon Plc (Ireland) ', 'Mollet Prazisionsmechanik AG (Switzerland) ', 'PAYER Group (Austria) ', 'RadiSurf (France) ', 'Rosti (Denmark) ', 'Tornos (Switzerland) ', 'Fareva Holdings SA (France) ', 'Recipharm AB (Sweden) ', 'Boehringer Ingelheim Group (Germany) '

    Government initiatives to improve patient outcomes and safety, rising unstructured information in the health care system, an aging population and the prevalence of chronic diseases, and improved health IT infrastructure are the factors responsible for the growth of the European healthcare quality management market over the forecast timeframe.

    Emphasis on Value-based care: In healthcare, Europe is establishing the foundation for value-based care. European governments are currently experimenting with various approaches to sharing risks and rewards among payers, healthcare providers, and pharmaceutical or medical-device manufacturers. Furthermore, several discussions, events, and conferences on value-based care are being held in Europe to assess its feasibility, promote its benefits, develop policies, and discuss the opportunities and challenges.

    The United Kingdom is leading the European quality management market in healthcare with the largest share during the forecast period, followed by Germany and France. The region's large share is primarily due to the increasing need to reduce rising healthcare costs while also improving patient outcomes, stringent legislative and accreditation requirements for healthcare quality reporting, the change from fee-for-service to value-based care, increasing patient volume of data, and greater awareness and adoption of healthcare IT technologies.

    Feedback From Our Clients

    European Quality Management In Healthcare Market

    Report ID: SQMIR35D2244

    $3,500
    BUY NOW